The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
ARCA biopharma, Inc. and Oruka Therapeutics announced that they have entered into a definitive agreement to combine the companies in an all-stock ...
read more
The FDA approved Zevtera (ceftobiprole medocaril sodium for injection) for the treatment of adults with Staphylococcus aureus bloodstream infections (...
read more
Morris & Dickson announced it is the first U.S. distributor of Bavarian Nordic’s newly launched mpox vaccine, JYNNEOS®. As the only FDA-approved mpox ...
read more
Merck announced the initiation of a Phase 3 clinical trial evaluating MK-1084, an investigational oral selective KRAS G12C inhibitor, in combination ...
read more
Cardinal Health announced that construction has begun for a new 350,000 square-foot logistics center in Columbus, Ohio, that will serve as a ...
read more
Otsuka Pharmaceutical, Co. Ltd. and Click Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn™ (developed...
read more
Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, announced the appointment of Karen Heim as Vice President and General Manager, Canada, ...
read more
AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the ...
read more
Myrtelle Inc. announced that the FDA granted Regenerative Medicine Advanced Therapy (RMAT) Designation to the Company's lead gene therapy product ...
read more
Ipsen and Sutro Biopharma announced an exclusive global licensing agreement for STRO-003. STRO-003, an antibody-drug conjugate (ADC) in the final ...
read more
Agilent Technologies Inc. and the University of California San Diego (UC San Diego), one of the top-ranked public research universities in the world, ...
read more
Apotex Inc. and Searchlight Pharma Inc. announced that they have reached an agreement whereby Apotex will acquire Searchlight.
read more
AvKARE, LLC. is voluntarily recalling lot # AW0221A of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level, due to the potential ...
read more
The Board of Directors of Lonza announced that Wolfgang Wienand has been appointed Chief Executive Officer (CEO), and will join the company during the...
read more
Bora Pharmaceuticals Co., Ltd. announced that it has completed the acquisition of Upsher-Smith Laboratories, Inc. (“Upsher-Smith”), a generics ...
read more